Biomedical advances have dramatically changed the landscape of HIV prevention and treatment domestically and globally. Pre-exposure prophylaxis (PrEP), vaginal microbicides, male circumcision, and antiretroviral therapy (ART) for prevention of mother-to-child transmission (PMTCT) have all been shown to reduce transmission in large trials, improve availability and access to ART and result in significant reductions in morbidity and mortality in HIV-infected infants, children and adults;Moreover, people with treatment-induced suppression of HIV viremia are less likely to infect others. As exciting as these biomedical advances are, they all depend on sustained changes in human behavior, and success of any future vaccine depends on acceptance and uptake and potentially, adherence to multiple doses over time. In 2006, the HU CFAR held a Strategic Planning Meeting in which the membership recognized the need for increased behavioral science efforts to examine how psychosocial and contextual factors influence HIV-related behaviors and to identify intervention points. This led to formation of the Behavioral and Social Sciences Program (BSSP) within the HU CFAR. As this has grown, there has been an increased need to provide behavioral/social science services to HU CFAR members and to mentor junior faculty and fellows. In addition, there has been an increasing need for integration of behavioral science into the context of HIV treatment programs and vaccine development. To this end, the Behavioral and Social Sciences Core has been established, to not just as a convener, but also provide critical services to the membership that are otherwise not available. The new Behavioral and Social Sciences Core will have the following specific aims: 1. To provide collaborative and consultation services to HU'CFAR members on behavioral and social science aspects of HIV prevention, treatment, and translational research projects. 2. To leverage infrastructure from HU CFAR biomedical projects to develop new behavioral/social science studies. 3. To foster community-based-participatory research and community engagement by providing a scientific and organizational base for HU CFAR's Community Programs.

Public Health Relevance

We propose a Behavioral and Social Sciences Core for the Harvard University Center for AIDS Research that will provide services to behavioral and biomedical researchers;will leverage ongoing biomedical projects to integrate behavioral/social science and conduct add-on behavioral/ social science studies;and will engage community stakeholders to increase buy-in of research and acceptance of new biomedical technologies.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Harvard Medical School
United States
Zip Code
Ballandras-Colas, Allison; Brown, Monica; Cook, Nicola J et al. (2016) Cryo-EM reveals a novel octameric integrase structure for betaretroviral intasome function. Nature 530:358-61
Jain, Sachin; Oldenburg, Catherine E; Mimiaga, Matthew J et al. (2016) High Levels of Concomitant Behavioral Health Disorders Among Patients Presenting for HIV Non-occupational Post-exposure Prophylaxis at a Boston Community Health Center Between 1997 and 2013. AIDS Behav 20:1556-63
Sunshine, Sara; Kirchner, Rory; Amr, Sami S et al. (2016) HIV Integration Site Analysis of Cellular Models of HIV Latency with a Probe-Enriched Next-Generation Sequencing Assay. J Virol 90:4511-9
Krakower, Douglas S; Mayer, Kenneth H (2016) Renal Function and Tenofovir Disoproxil Fumarate for Preexposure Prophylaxis: How Safe Is Safe Enough? J Infect Dis 214:983-5
Mayer, Kenneth H; Krakower, Douglas S; Boswell, Stephen L (2016) Antiretroviral Preexposure Prophylaxis: Opportunities and Challenges for Primary Care Physicians. JAMA 315:867-8
Saito, Akatsuki; Henning, Matthew S; Serrao, Erik et al. (2016) Capsid-CPSF6 Interaction Is Dispensable for HIV-1 Replication in Primary Cells but Is Selected during Virus Passage In Vivo. J Virol 90:6918-35
Krakower, Douglas S; Maloney, Kevin M; Grasso, Chris et al. (2016) Primary care clinicians' experiences prescribing HIV pre-exposure prophylaxis at a specialized community health centre in Boston: lessons from early adopters. J Int AIDS Soc 19:21165
Brown, Carolyn A; Suneja, Gita; Tapela, Neo et al. (2016) Predictors of Timely Access of Oncology Services and Advanced-Stage Cancer in an HIV-Endemic Setting. Oncologist 21:731-8
McDavitt, Bryce; Bogart, Laura M; Mutchler, Matt G et al. (2016) Dissemination as Dialogue: Building Trust and Sharing Research Findings Through Community Engagement. Prev Chronic Dis 13:E38
Gandhi, Rajesh T; Kwon, Douglas S; Macklin, Eric A et al. (2016) Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial. J Acquir Immune Defic Syndr 71:246-53

Showing the most recent 10 out of 844 publications